Effects of VEGFR-3 phosphorylation inhibitor on lymph node metastasis in an orthotopic diffuse-type gastric carcinoma model
Open Access
- 29 September 2009
- journal article
- research article
- Published by Springer Nature in British Journal of Cancer
- Vol. 101 (7) , 1100-1106
Abstract
Vascular endothelial growth factor receptor-3 (VEGFR-3) signalling mediates lymphangiogenesis and lymphatic invasion; however, the effect of VEGFR-3 inhibition on the lymph node (LN) metastasis remains unclear. The aim of this study is to clarify the benefit of a VEGFR-3 inhibitor Ki23057 for LN metastasis. Ki23057 was administered orally to gastric cancer models created by orthotopic inoculation of diffuse-type gastric cancer cells, OCUM-2MLN. The effects of Ki23057 on lymphatic vessel invasion, lymphatic vessel density, and VEGFR-3 phosphorylation were examined by immunostaining or immunoblotting. Ki23057 inhibited the autophosphorylation of VEGFR-3, with IC50 values of 4.3 nM in the cell-free kinase assay. Murine gastric cancer models created by the orthotopic inoculation of OCUM-2MLN cells showed the diffusely infiltrating growth and frequently developed LN metastasis. The oral administration of Ki23057 significantly (PP<0.05) lower in the gastric tumours treated by Ki23057. Ki23057 inhibited the phosphorylation of VEGFR-3 of lymphatic endothelial cells in gastric tumours. The inhibition of lymphangiogenesis targeting VEGFR-3 phosphorylation is a therapeutic strategy for inhibiting LN metastasis of diffuse-type gastric cancer.Keywords
This publication has 25 references indexed in Scilit:
- A Novel Molecular Targeting Compound as K-samII/FGF-R2 Phosphorylation Inhibitor, Ki23057, for Scirrhous Gastric CancerGastroenterology, 2006
- Expression of vascular endothelial growth factor (VEGF)-C and -D in gastric carcinomaInternational Journal of Clinical Oncology, 2006
- Vascular Endothelial Growth Factor-D and Its Receptor VEGFR-3: Two Novel Independent Prognostic Markers in Gastric AdenocarcinomaJournal of Clinical Oncology, 2006
- CD54 Expression Is Predictive for Lymphatic Spread in Human Gastric CarcinomaDigestive Diseases and Sciences, 2005
- Peritumoral Lymphatic Vessel Density and Vascular Endothelial Growth Factor C Expression in Early-Stage Squamous Cell Carcinoma of the Uterine CervixClinical Cancer Research, 2005
- Inhibitory effect of a selective cyclooxygenase inhibitor on the invasion‐stimulating activity of orthotopic fibroblasts for scirrhous gastric cancer cellsCancer Science, 2005
- Quantitative analysis of lymphangiogenic markers for predicting metastasis of human gastric carcinoma to lymph nodesInternational Journal of Cancer, 2005
- Orally active anti-proliferation agents: novel diphenylamine derivatives as FGF-R2 autophosphorylation inhibitorsBioorganic & Medicinal Chemistry Letters, 2004
- The role of tumor lymphangiogenesis in metastatic spreadThe FASEB Journal, 2002
- Lymphangiogenesis in malignant tumours: does it occur?The Journal of Pathology, 2001